Paul MacLeman

Dr Paul MacLeman has over 25 years of board and executive experience across the life sciences, agricultural and not-for-profit sectors. This includes strategy formulation, capital raising, business development, technology commercialisation, sales & marketing. He has also launched a variety of products in Australia, US and Asia; founded life sciences startups in the biologics area; and worked in investment banking. Dr MacLeman is chair of AdAlta and Livac, and is non-executive director of Sypharma. He also chairs the committee reviewing the National Vocational Education Training Package in Pharmaceuticals, and had chaired the Committee to develop a nationally recognised Course in Pharmaceutical Manufacture for Victoria, the AusBiotech Agricultural Advisory Board. Dr MacLeman has been a managing director of Nasdaq, ASX and TSX listed companies.
Bio last updated 06 Oct 2018

Access to our data for Paul MacLeman is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Paul MacLeman is linked to 1 organisation which is included in 2 lists - Business News 30 and Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 31/10/18

1 year TSR5 year TSR
152ndAusCann Group Holdings33%50%
717thNeurotech International-56%0%
799thTech Mpire-72%-19%
744 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Executive Director
Year started and most recent title


209th↓Tech Mpire$73k
210th↓Neurotech International$67k
211th↓AusCann Group Holdings$54k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer